When you enter multiple keywords separated by space, your search will contain results that match any of the keywords (OR search).
  • 13 Hits
  • Search Condition : Filter (MeSH = Glioma / therapy*)
Species Resource
DNA material pRx nZ ires Neo (RDB01699) , pRxZiN (RDB01880). Efficient retrovirus-mediated cytokine-gene transduction of primary-cultured human glioma cells for tumor vaccination therapy.
DNA material pCAZ 2 (RDB01870) Generation of fiber-mutant recombinant adenoviruses for gene therapy of malignant glioma.
DNA material pCAEGFP (RDB03956) Antitumor effect of genetically engineered mesenchymal stem cells in a rat glioma model.
Human and Animal Cells Glioma immunotherapy with combined autologous tumor cell and endothelial cell vaccine in vivo.
DNA material pTnT-TUG1 exon1 (RDB15794) , pTnT-TUG1 exon2 (RDB15795) , pTnT-TUG1 exon3 (RDB15796). Targeting the Notch-regulated non-coding RNA TUG1 for glioma treatment.
DNA material pxCANCre (RDB01675) Glioma/glioblastoma-specific adenoviral gene expression using the nestin gene regulator.
Human and Animal Cells HFWT Autologous natural killer cell therapy for human recurrent malignant glioma.
Human and Animal Cells Accumulation of cell cycle regulatory proteins, p21 and p27, induced after hyperthermia in human glioma cells.
Human and Animal Cells Sterile alpha motif containing domain 9 is involved in death signaling of malignant glioma treated with inactivated Sendai virus particle (HVJ-E) or type I interferon.
Human and Animal Cells Marked enhancement of antitumor immune responses in mouse brain tumor models by genetically modified dendritic cells producing Semliki Forest virus-mediated interleukin-12.
Human and Animal Cells Administration of interleukin-12 and -18 enhancing the antitumor immunity of genetically modified dendritic cells that had been pulsed with Semliki forest virus-mediated tumor complementary DNA.
Human and Animal Cells Enhancement of thymidine kinase-mediated killing of malignant glioma by BimS, a BH3-only cell death activator.
Human and Animal Cells Generation of fiber-mutant recombinant adenoviruses for gene therapy of malignant glioma.